Why the study?
Does transcatheter aortic valve replacement improve health-related quality of life compared to standard therapy in inoperable patients with severe aortic stenosis?
Population
358 patients with symptomatic, severe aortic stenosis who were not candidates for surgical valve replacement
Comparison
Transcatheter aortic valve replacement (TAVR) vs Standard therapy
Design
RCT, randomized
Follow-up
12 months
Authors
Loading...
Supports TAVR for inoperable severe aortic stenosis; extends survival data with patient-reported outcomes.
Does transcatheter aortic valve replacement improve health-related quality of life compared to standard therapy in inoperable patients with severe aortic stenosis?
In inoperable patients with severe aortic stenosis, TAVR significantly improves health-related quality of life compared to standard therapy at 1 year.
Reynolds et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: